S 1141 United States Senate · 118th Congress

HALT Fentanyl Act

The HALT Fentanyl Act (S 1141) creates a new, broader definition for "fentanyl-related substances" under the Controlled Substances Act, making many chemical variations subject to Schedule I restrictions without needing individual listing. It establishes streamlined research registration procedures for scientists studying these substances, allowing single registrations for multi-site research within institutions and creating expedited processes for new research applications. The bill also includes provisions to allow ongoing research on substances newly added to Schedule I, with specific timelines for researchers to transition to full registration. These changes aim to balance strict controls on fentanyl-related substances with the need for medical research on these compounds.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2023
Committee Review
Floor Vote
President
Introduced Mar 30, 2023 Last action Mar 30, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 30, 2023
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Mar 30, 2023
Introduced
Introduced in Senate
upper
1 primary · 8 co-sponsors

Sponsors